ETTA, Miss., Feb. 12, 2026 (GLOBE NEWSWIRE) — As Valentine’s Day approaches, Oxford Treatment Center emphasizes the critical role of joint recovery for couples affected by substance misuse, offering a specialized couples rehab program at its Etta campus to address the unique challenges these partnerships face. When both partners are struggling with substance use, the impact […]
Category Archives: Pr Newswire
Pr Newswire
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
13
Feb
Feb
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the fourth quarter and full year of 2025 before […]
Pr Newswire
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
13
Feb
Feb
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 Company to Host Conference Call with Live Q&A, February 26, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – February 12, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will […]
SAN FRANCISCO and SUZHOU, China, Feb. 13, 2026 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”,HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the first participant has been successfully dosed in the pivotal Phase 3 clinical […]
– Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modulating properties, and the execution of high-value commercial partnerships in South Korea and Vietnam. NEW TAIPEI CITY, Feb. 13, 2026 /PRNewswire/ — Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the […]
Bruce Munro’s original installation reaches 750,000 visitors as new art, guest experiences and cultural collaborations are unveiled by Ayers Rock Resort, Uluṟu. SYDNEY, Feb. 13, 2026 /PRNewswire/ — One of the world’s most recognisable large-scale light installations, Bruce Munro’s Field of Light, marks its 10th anniversary in 2026, celebrated with events and collaborations across Australia. Opening in […]
Cash-settled Russell 2000® Index (RUT) options now available during Cboe’s Global Trading Hours Cboe now offers nearly 24×5 trading for RUT, S&P 500 Index and Cboe Volatility Index options RUT options and Cboe’s Global Trading Hours both reached record volumes in 2025 CHICAGO, Feb. 13, 2026 /PRNewswire/ — Cboe Global Markets, Inc. (Cboe: CBOE), the world’s […]
Elliott does not intend to tender its shares into the Extended TOB at the current terms Elliott strongly encourages other shareholders not to tender and to withdraw any shares already tendered LONDON, Feb. 13, 2026 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together have a significant investment […]
Pr Newswire
NMD Pharma results from Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2 selected for late-breaking oral presentation at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
12
Feb
Feb
Aarhus, Denmark, 12 February 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announced that top-line data results from its Phase 2a SYNAPSE-CMT study evaluating ignaseclant (formerly known as NMD670) in patients living with Charcot-Marie-Tooth disease (CMT) types 1 or 2 has been accepted […]
12
Feb
Feb
Integration of HiFi Long-Read Whole-Genome Sequencing Expands the Collective Capabilities of iHope’s Global Rare Disease Network MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global rare disease genomics program of Genetic Alliance, to integrate PacBio’s HiFi® […]